BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

980 related articles for article (PubMed ID: 37217462)

  • 1. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.
    Yang J; Xu J; Wang W; Zhang B; Yu X; Shi S
    Signal Transduct Target Ther; 2023 May; 8(1):210. PubMed ID: 37217462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Epigenetic-Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment.
    Zhang J; Huang L; Ge G; Hu K
    Adv Sci (Weinh); 2023 Mar; 10(7):e2206169. PubMed ID: 36599655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy.
    Loo Yau H; Ettayebi I; De Carvalho DD
    Trends Cell Biol; 2019 Jan; 29(1):31-43. PubMed ID: 30153961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe.
    Niu Y; Chen J; Qiao Y
    Front Immunol; 2022; 13():836223. PubMed ID: 35140725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment.
    Pan X; Zheng L
    Cell Mol Immunol; 2020 Sep; 17(9):940-953. PubMed ID: 32699350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Epigenetics, Tumor Immunity, and Immunotherapy.
    Cao J; Yan Q
    Trends Cancer; 2020 Jul; 6(7):580-592. PubMed ID: 32610068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the epigenetic regulation of antitumour immunity.
    Hogg SJ; Beavis PA; Dawson MA; Johnstone RW
    Nat Rev Drug Discov; 2020 Nov; 19(11):776-800. PubMed ID: 32929243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Regulations in Autoimmunity and Cancer: from Basic Science to Translational Medicine.
    Hui L; Ziyue Z; Chao L; Bin Y; Aoyu L; Haijing W
    Eur J Immunol; 2023 Apr; 53(4):e2048980. PubMed ID: 36647268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the RNA m
    Li X; Ma S; Deng Y; Yi P; Yu J
    Mol Cancer; 2022 Mar; 21(1):76. PubMed ID: 35296338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies.
    Trnkova L; Buocikova V; Mego M; Cumova A; Burikova M; Bohac M; Miklikova S; Cihova M; Smolkova B
    Biomed Pharmacother; 2024 May; 174():116559. PubMed ID: 38603889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment.
    Zhou L; Yu CW
    Pharmacol Res; 2024 Jun; 204():107205. PubMed ID: 38719195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer.
    Luo H; Shan J; Zhang H; Song G; Li Q; Xu CX
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):960-970. PubMed ID: 35189321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy.
    Komar D; Juszczynski P
    Clin Epigenetics; 2020 Oct; 12(1):147. PubMed ID: 33054831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the chromatin structural changes of antitumor immunity.
    Li NN; Lun DX; Gong N; Meng G; Du XY; Wang H; Bao X; Li XY; Song JW; Hu K; Li L; Li SY; Liu W; Zhu W; Zhang Y; Li J; Yao T; Mou L; Han X; Hao F; Hu Y; Liu L; Zhu H; Wu Y; Liu B
    J Pharm Anal; 2024 Apr; 14(4):100905. PubMed ID: 38665224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression.
    Saleh R; Toor SM; Sasidharan Nair V; Elkord E
    Front Immunol; 2020; 11():1469. PubMed ID: 32760400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications.
    Zhu D; Zeng S; Su C; Li J; Xuan Y; Lin Y; Xu E; Fan Q
    Clin Epigenetics; 2024 Feb; 16(1):24. PubMed ID: 38331927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics and immunotherapy: The current state of play.
    Dunn J; Rao S
    Mol Immunol; 2017 Jul; 87():227-239. PubMed ID: 28511092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications.
    Yin J; Gu T; Chaudhry N; Davidson NE; Huang Y
    Front Immunol; 2023; 14():1325615. PubMed ID: 38268926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of epigenetic modifications in the head and neck tumour microenvironment.
    Liu H; Wang D; Yang Z; Li S; Wu H; Xiang J; Kan S; Hao M; Liu W
    Front Immunol; 2022; 13():1050982. PubMed ID: 36405713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging epigenetics to enhance the efficacy of immunotherapy.
    Licht JD; Bennett RL
    Clin Epigenetics; 2021 May; 13(1):115. PubMed ID: 34001289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.